No free trial, and no waiting on a validation study before you can start. You run the Bioscreen on your own patients, pay only for the ones you actually send, and decide at the end of a thirty-day review period whether to carry on.
One price per patient for Core Plus: the screen plus full module access for thirty days from your results. It is all in, covering the collection kit, shipping and the phlebotomy draw, so nothing is billed to your patient on top.
29% below the $2,095 standard rate. Submit as few as one patient and as many as five, and you are invoiced only for the ones you actually send, on delivery of each report, net 30. A sample that fails laboratory quality control is not invoiced.
One seat with full Clinical Surveillance and the peptide efficacy and regulatory feed, at no charge from signature through your decision date. Surveillance covers patients you have never assayed, and does not cost extra.
We walk you through each report and the portal before you are asked to act on it. The walkthrough is delivered by a member of our team who is not a clinician: it explains what the report contains and how a result was derived, and it is not clinical advice.
Every pilot practice is a design partner. You tell us what is missing in the room and the roadmap bends toward it, which is possible precisely because the founding cohort is capped at fifty.
We stopped giving the first five away. You pay for your own patients’ reports, which is what makes this a real test of whether the thing is worth buying.
Up to five workups at $1,485 each, a free practitioner seat through your decision date, a walkthrough of every report, and founding rates locked for twelve months if you carry on.
That you run it on patients you genuinely have questions about, tell us candidly what works and what does not, and give us a decision in writing by the end of the review period, either way.
So you know exactly what you are locking in before you start.
$1,485 a patient, and a flat $199 per practitioner per month however many patients you monitor, for twelve months from your decision date. The tiers below do not apply while the lock runs.
$2,095 for the Core Plus assay: the screen and full module access for thirty days from results, kit, shipping and the draw included. There is no lesser tier and nothing is held back for an upgrade. The practitioner subscription is the only tiered pricing, and it steps at $199, $355 and $575 a month, set by how many assayed patients are under active monitoring. Monitoring of patients you have not assayed stays unlimited and never moves the tier.